ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Molecular Instruments Launches HCR™ Pro RNA-ISH for Manual Workflows, Enabling Extreme-Sensitivity RNA Imaging in an Accessible Format

Molecular Instruments® (MI), inventor of the HCR™ technology, today announces the launch of HCR™ Pro RNA-ISH for manual workflows, expanding the unmatched performance and versatility of the HCR™ imaging platform by enabling extreme-sensitivity RNA imaging with chromogenic or fluorescent staining in an accessible and flexible format tailored for hands-on research applications.

HCR™ Pro RNA-ISH integrates enzymatic signal amplification to enable extreme-sensitivity RNA imaging for the most demanding targets/samples when signal-to-background is at an absolute premium. For example, the assay facilitates rapid scanning of a low-expression target in a highly-autofluorescent sample over a large field-of-view at low magnification.

“HCR™ products are known for redefining what’s possible for RNA imaging in challenging contexts,” said Cameron Earl, Director of Product Management at Molecular Instruments. “HCR™ Pro has already elevated that standard on the leading automated platforms. Now we’re excited to offer the extreme sensitivity of HCR™ Pro RNA-ISH to researchers using manual assays on the full gamut of sample types from whole-mount embryos to ultrathick brain slices.”

HCR™ Pro RNA-ISH pioneers entirely protease-free workflows in tissue sections, preserving sample morphology and maintaining protein target integrity, enabling seamless compatibility with existing immunohistochemistry (IHC)/immunofluorescence (IF) assays.

The assay employs HCR™ HiFi Probes available from MI’s Infinite Catalog for any target RNA in any organism across the tree of life with no design fee and backed by the HCR™ HiFi Probe Promise. Chromogenic staining offers the convenience of brightfield microscopy and the option of archival staining. Fluorescent staining offers the convenience of spectrally distinct channels for multiplex RNA-FISH/IF workflows.

Learn more about manual HCR™ Pro RNA-ISH.

About Molecular Instruments

Molecular Instruments® (www.molecularinstruments.com) develops and synthesizes molecular kits powered by the breakthrough HCR™ imaging platform for applications in academic research, drug development, synthetic biology, and clinical pathology and diagnostics.

HCR™ Pro RNA-ISH enables extreme-sensitivity RNA imaging with chromogenic or fluorescent staining in an accessible and flexible format.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.68
+1.46 (0.63%)
AAPL  281.12
+2.27 (0.81%)
AMD  219.92
+2.39 (1.10%)
BAC  53.44
-0.21 (-0.40%)
GOOG  316.05
-4.07 (-1.27%)
META  642.58
-5.37 (-0.83%)
MSFT  488.52
-3.49 (-0.71%)
NVDA  179.28
+2.28 (1.29%)
ORCL  201.34
-0.61 (-0.30%)
TSLA  427.85
-2.32 (-0.54%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.